Arrowhead Pharmaceuticals Inc. (ARWR) Reports Q1 Loss of $0.20
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/3/2026
- Nasdaq ends higher as AI heavyweights rebound ahead of midterm results
- Apple shares slip amid guidance for tightening margins, slowing services growth
- Rising shorts cool U.S. large-cap positioning, cutting liquidation risk: Citi
- Apple's 'unprecedented' memory warning adds fuel to wobbly Micron, SK hynix trade
- Palantir raises 2026 revenue outlook after quarterly revenue nearly doubles on AI
| ARROWHEAD RESEARCH (NASDAQ: ARWR) | Delayed: 59.53 -0.04 (0.07%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $59.57 | 52 Week High | $8.22 | |||
| Open | $59.60 | 52 Week Low | $3.07 | |||
| Day High | $60.89 | P/E | N/A | |||
| Day Low | $59.25 | EPS | $-1.30 | |||
| Volume | 1,327,195 | |||||
